New assessment of hepatic encephalopathy

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Teaching NeuroImages Neurology Resident and Fellow Section
Inflammasomes in liver diseases
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Volume 68, Issue 5, Pages (May 2018)
Volume 61, Issue 6, Pages (December 2014)
The impact of hepatitis E in the liver transplant setting
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Non-invasive diagnosis of non-alcoholic fatty liver disease
Marcus-Alexander Wörns, Peter Robert Galle  Journal of Hepatology 
Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute- on-chronic liver failure  Manuel Romero-Gómez, Sara Montagnese, Rajiv.
Primovist, Eovist: What to expect?
Living donor liver transplantation: is the hype over?
Human serum albumin, systemic inflammation, and cirrhosis
Volume 69, Issue 2, Pages (August 2018)
Autoimmune hepatitis Journal of Hepatology
Volume 44, Pages S19-S24 (January 2006)
Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure”  Rakhi Maiwall,
ART score for retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma: Is it really applicable?  Jian Wu, Wei Bai,
New imaging techniques for liver diseases
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
European Association for the Study of the Liver  Journal of Hepatology 
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Volume 68, Issue 1, Pages (January 2018)
Riccardo Lencioni, Fabio Piscaglia, Luigi Bolondi 
Volume 65, Issue 2, Pages (August 2016)
Acute-on chronic liver failure
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Vicente Arroyo, Carlos Terra, Pere Ginès  Journal of Hepatology 
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Volume 59, Issue 1, Pages (July 2013)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Andres Cardenas, Pere Ginès  Journal of Hepatology 
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
EASL Clinical Practice Guidelines: Wilson’s disease
1H-MR-spectroscopy water-suppressed proton spectra of an 8-mL voxel located in the parietal region including predominantly normal-appearing white matter.
The heart in liver transplantation
Clinical states of cirrhosis and competing risks
Wolfgang Sieghart, Florian Hucke, Markus Peck-Radosavljevic 
The changing role of beta-blocker therapy in patients with cirrhosis
Theresa Hydes, William Gilmore, Nick Sheron, Ian Gilmore 
Volume 57, Issue 5, Pages (November 2012)
Fibrosis in chronic liver diseases: diagnosis and management
Established and novel imaging biomarkers for assessing response to therapy in hepatocellular carcinoma  Tao Jiang, Andrew X. Zhu, Dushyant V. Sahani 
Portal vein thrombosis, cirrhosis, and liver transplantation
Non-invasive evaluation of liver fibrosis using transient elastography
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
Volume 64, Issue 6, Pages (June 2016)
Volume 63, Issue 1, Pages (July 2015)
Primovist, Eovist: What to expect?
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice  Paolo Angeli, Pere Gines 
Volume 62, Issue 3, Pages (March 2015)
Volume 66, Issue 4, Pages (April 2017)
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Sara Montagnese, Michele De Rui, Paolo Angeli, Piero Amodio 
Approaches for patients with very high MELD scores
A, Baseline MR imaging study (transverse fast FLAIR T2-weighted image) of a 56-year-old patient with hepatitis C cirrhosis without overt hepatic encephalopathy.
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Images from the case of an 8-year-old female patient with complex I mitochondrial disease, which was diagnosed when the patient was older than 3 years.
PHES: One label, different goods?!
Presentation transcript:

New assessment of hepatic encephalopathy Juan Córdoba  Journal of Hepatology  Volume 54, Issue 5, Pages 1030-1040 (May 2011) DOI: 10.1016/j.jhep.2010.11.015 Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Cognitive function assessment in HE can be performed with a categorical or a continuous approach. In the categorical approach, the criteria that define the categories are arbitrary and vary between raters. In the continuous approach, patients may be unimpaired (lack of cognitive impairment) or impaired (unstable or stable), and may move from one situation to another or remain stable for long periods of time. Those that are unstable exhibit an acute confusional syndrome (that can progress to coma). Those that are impaired, but stable, show chronic low-grade HE that may be covert (only revealed by psychometric tests) or overt (obvious on clinical exam). Patients with prolonged and severe cognitive deficits (dementia) are diagnosed as having persistent severe HE or acquired hepatocerebral degeneration (when associated with motor manifestations). There is some overlapping between the grades of the categorical approach and the situations defined in the continuous approach, but there is no direct correspondence. Journal of Hepatology 2011 54, 1030-1040DOI: (10.1016/j.jhep.2010.11.015) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 2 MR of the brain in a patient exhibiting grade II HE, and repeated 6 weeks later when the patient exhibited minimal HE. (A) (fast-FLAIR) shows hyperintense focal white matter lesions (leukoaraiosis) that decrease in volume after the resolution of HE. (B) (MR-spectroscopy) at follow-up shows decrease of the high glutamine-containing (Glx) peak and increase of the low of myo-inositol (mIns) peak. The other peaks correspond to choline-containing compounds (Cho), n-acetyl-aspartate (NAA), and creatine (Cr). Journal of Hepatology 2011 54, 1030-1040DOI: (10.1016/j.jhep.2010.11.015) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Dynamic helical CT scanning discloses a splenorenal shunt (arrow) during the arterial phase (left image) that becomes more evident in the venous phase (right image). Journal of Hepatology 2011 54, 1030-1040DOI: (10.1016/j.jhep.2010.11.015) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 4 Evaluation of a patient with cirrhosis and an acute change in mental status should be initiated by excluding toxic, metabolic, and structural encephalopathies. In parallel, the patient should be assessed following a protocol to investigate precipitating factors and undergo blood tests and imaging studies to evaluate liver function and portal-systemic circulation. According to the results, patients are classified as episodic HE, acute-on-chronic liver failure, or terminal liver disease, and are managed accordingly. Journal of Hepatology 2011 54, 1030-1040DOI: (10.1016/j.jhep.2010.11.015) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 5 Asymptomatic outpatients with cirrhosis at risk of experiencing an accident should undergo additional tests to investigate the presence of low-grade HE. Preventive measures should be recommended for those with abnormal results. Neuropsychological assessment should be more detailed and may require expert advice in patients who want to keep on driving. Journal of Hepatology 2011 54, 1030-1040DOI: (10.1016/j.jhep.2010.11.015) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2011 54, 1030-1040DOI: (10. 1016/j. jhep. 2010 Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2011 54, 1030-1040DOI: (10. 1016/j. jhep. 2010 Copyright © 2010 European Association for the Study of the Liver Terms and Conditions